USE OF INSULIN DEGRADING ENZYME (IDE) FOR THE TREATMENT OF ALZHEIMERS DISEASE PATIENTS - 0958
- Technology Benefits
- IDEcleaves targeted amyloid peptides into innocuous byproducts and eliminatestoxicity. It also acts intracellulary and inactivates amyloid peptides prior tosecretion.
- Detailed Technology Description
- None
- *Abstract
-
None
- Country/Region
- USA
For more information, please click Here

